Soheilifar S, Fathi H, Naghdi N. Photobiomodulation therapy as a high potential treatment modality for COVID-19. Lasers Med Sci. 2021;36:935–8.

Article  PubMed  Google Scholar 

Bian J, Liebert A, Bicknell B, Chen X-M, Huang C, Pollock CA. Therapeutic potential of photobiomodulation for chronic kidney disease. IJMS. 2022;23:8043.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cardoso FDS, Salehpour F, Coimbra NC, Gonzalez-Lima F, Gomes Da Silva S. Photobiomodulation for the treatment of neuroinflammation: a systematic review of controlled laboratory animal studies. Front Neurosci. 2022;16:1006031.

Article  PubMed  PubMed Central  Google Scholar 

Lin H, Li D, Zhu J, Liu S, Li J, Yu T, et al. Transcranial photobiomodulation for brain diseases: review of animal and human studies including mechanisms and emerging trends. Neurophoton. 2024. https://doi.org/10.1117/1.NPh.11.1.010601.full.

Article  Google Scholar 

Ma H, Du Y, Xie D, Wei ZZ, Pan Y, Zhang Y. Recent advances in light energy biotherapeutic strategies with photobiomodulation on central nervous system disorders. Brain Res. 2024;1822: 148615.

Article  CAS  PubMed  Google Scholar 

Reinhart F, Massri NE, Darlot F, Torres N, Johnstone DM, Chabrol C, et al. 810nm near-infrared light offers neuroprotection and improves locomotor activity in MPTP-treated mice. Neurosci Res. 2015;92:86–90.

Article  PubMed  Google Scholar 

Gordon LC, Martin KL, Torres N, Benabid A, Mitrofanis J, Stone J, et al. Remote photobiomodulation targeted at the abdomen or legs provides effective neuroprotection against parkinsonian MPTP insult. Eur J Neurosci. 2023;57:1611–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muili KA, Gopalakrishnan S, Meyer SL, Eells JT, Lyons J-A. Amelioration of experimental autoimmune encephalomyelitis in C57BL/6 mice by photobiomodulation induced by 670 nm light. PLoS ONE. 2012;7:e30655.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Muili KA, Gopalakrishnan S, Eells JT, Lyons J-A. Photobiomodulation induced by 670 nm light ameliorates MOG35-55 induced EAE in female C57BL/6 mice: a role for remediation of nitrosative stress. PLoS ONE. 2013;8:e67358.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gonçalves ED, Souza PS, Lieberknecht V, Fidelis GSP, Barbosa RI, Silveira PCL, et al. Low-level laser therapy ameliorates disease progression in a mouse model of multiple sclerosis. Autoimmunity. 2016;49:132–42.

Article  PubMed  Google Scholar 

Blivet G, Meunier J, Roman FJ, Touchon J. Neuroprotective effect of a new photobiomodulation technique against Aβ25–35 peptide-induced toxicity in mice: novel hypothesis for therapeutic approach of Alzheimer’s disease suggested. Alzheimer’s Dementia Transl Res Clin Intervent. 2018;4:54–63.

Article  Google Scholar 

Monteiro F, Carvalho Ó, Sousa N, Silva FS, Sotiropoulos I. Photobiomodulation and visual stimulation against cognitive decline and Alzheimer’s disease pathology: a systematic review. A&D Transl Res & Clin Interv. 2022;8: e12249.

Article  Google Scholar 

Blivet G, Relano-Gines A, Wachtel M, Touchon J. A randomized, double-blind, and sham-controlled trial of an innovative brain-gut photobiomodulation therapy: safety and patient compliance. JAD. 2022;90:811–22.

Article  CAS  PubMed  Google Scholar 

Silva T, Fragoso YD, Destro Rodrigues MFS, Gomes AO, Da Silva FC, Andreo L, et al. Effects of photobiomodulation on interleukin-10 and nitrites in individuals with relapsing-remitting multiple sclerosis—randomized clinical trial. PLoS ONE. 2020;15:e0230551.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamblin MR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018;94:199–212.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Joniová J, Gerelli E, Wagnières G. Study and optimization of the photobiomodulation effects induced on mitochondrial metabolic activity of human cardiomyocytes for different radiometric and spectral conditions. Life Sci. 2024;351: 122760.

Article  PubMed  Google Scholar 

Amaroli A, Clemente Vargas MR, Pasquale C, Raffetto M, Ravera S. Photobiomodulation on isolated mitochondria at 810 nm: first results on the efficiency of the energy conversion process. Sci Rep. 2024;14:11060.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pope NJ, Denton ML. Differential effects of 808-nm light on electron transport chain enzymes in isolated mitochondria: implications for photobiomodulation initiation. Mitochondrion. 2023;68:15–24.

Article  CAS  PubMed  Google Scholar 

Foo ASC, Soong TW, Yeo TT, Lim K-L. Mitochondrial dysfunction and Parkinson’s disease—near-infrared photobiomodulation as a potential therapeutic strategy. Front Aging Neurosci. 2020;12:89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Charabati M, Wheeler MA, Weiner HL, Quintana FJ. Multiple sclerosis: neuroimmune crosstalk and therapeutic targeting. Cell. 2023;186:1309–27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pozzilli C, Pugliatti M, Vermersch P, Grigoriadis N, Alkhawajah M, Airas L, et al. Diagnosis and treatment of progressive multiple sclerosis: a position paper. Euro J Neurol. 2023;30:9–21.

Article  Google Scholar 

Harirchian MH, Fatehi F, Sarraf P, Honarvar NM, Bitarafan S. Worldwide prevalence of familial multiple sclerosis: a systematic review and meta-analysis. Mult Scler Relat Disord. 2018;20:43–7.

Article  PubMed  Google Scholar 

Patsopoulos NA. Genetics of multiple sclerosis: an overview and new directions. Cold Spring Harb Perspect Med. 2018;8: a028951.

Article  PubMed  PubMed Central  Google Scholar 

Barrie W, Yang Y, Irving-Pease EK, Attfield KE, Scorrano G, Jensen LT, et al. Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations. Nature. 2024;625:321–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schroeter CB, Huntemann N, Bock S, Nelke C, Kremer D, Pfeffer K, et al. Crosstalk of microorganisms and immune responses in autoimmune neuroinflammation: a focus on regulatory T cells. Front Immunol. 2021;12: 747143.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas OG, Olsson T. Mimicking the brain: Epstein-Barr virus and foreign agents as drivers of neuroimmune attack in multiple sclerosis. Front Immunol. 2023;14:1304281.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lanz TV, Brewer RC, Ho PP, Moon J-S, Jude KM, Fernandez D, et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature. 2022;603:321–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science. 2022;375:296–301.

Article  CAS  PubMed  Google Scholar 

Bakhshi A, Eslami N, Norouzi N, Letafatkar N, Amini-Salehi E, Hassanipour S. The association between various viral infections and multiple sclerosis: an umbrella review on systematic review and meta-analysis. Rev Med Virol. 2024;34: e2494.

Article  PubMed  Google Scholar 

Wiendl H, Gold R, Berger T, Derfuss T, Linker R, Mäurer M, et al. Multiple Sclerosis Therapy Consensus Group (MSTCG): position statement on disease-modifying therapies for multiple sclerosis (white paper). Ther Adv Neurol Disord. 2021;14:175628642110396.

Article  Google Scholar 

Macaron G, Larochelle C, Arbour N, Galmard M, Girard JM, Prat A, et al. Impact of aging on treatment considerations for multiple sclerosis patients. Front Neurol. 2023;14:1197212.